Modified low density lipoproteins (LDL), including their oxidized forms, have been widely implicated in the etiology of atherosclerosis and concomitant cardiovascular disease (CVD) in chronic renal failure (CRF). The nature of events that lead to oxidative changes in LDL proteins are not clearly understood. Thus, patients suffering from CRF were grouped into mild, moderate and severe categories based on their blood urea and serum creatinine levels. Progression of CRF was accompanied not only with gradual increase in serum malondialdehyde (MDA) but also parallel increase in conjugated diene and MDA levels in LDL fractions separated from serum. Serum superoxide dismutase (SOD) activity was concurrently found to decrease, along with a decrease in high-density lipoprotein (HDL) cholesterol, during the progression of CRF. Gradual increase in the appearance of LDL oxidation products seems to accompany progressive manifestation of CRF. The results presented suggest that determination of serum MDA and SOD levels may enhance the diagnostic significance of the study of lipid profile in determining the risk for cardio vascular disease in CRF.
INTRODUCTION
It is well known that the incidence of cardiovascular disease is the major cause of mortality in patients suffering from chronic renal failure (CRF) and that the process of atherosclerosis is accelerated in CRF (1).
Increased amounts of modified low density lipoproteins (LDL), particularly the oxidised LDL, 
MATERIALS AND METHODS

Subjects and Sampling
Patients suffering from CRF were randomly selected for the study. Based on serum creatinine levels the patients were categorized into three stages as per standard clinical notation (13).
Stage I patients had serum creatinine levels ranging from 1.5 to 3.0 mg/dl; Stage II patients had serum creatinine levels in the range of 3.1 -8.0 mg/dl and those patients with serum creatinine above 8.0 mg/dl were grouped under Stage II1.
Each group consisted of at least a minimum of 10-12 patients of the same age group (30-50 yr.).
Simultaneous determinations were made in 12, age-matched, normal healthy individuals to serve as the controls. Blood samples were collected under fasting conditions and analyzed for serum levels of urea, creatinine, uric acid, calcium, phosphorous, alkaline phosphatase, amylase, electrolytes and lipid profiles. Blood samples were drawn in EDTA for isolation of LDL and for analysis of LDL oxidative products.
Methods
Lipid profile : Total cholesterol, triglycerides, HDL cholesterol were determined using commercial kits (Boerhinger Mannheim) employing a semiautoanlyser (Eppendorf E com F 6124).
Maiondialdehyde : Serum malon-dialdehyde (MDA) levels were estimated following the method described by Sadasivudu et. al. (14) which is a slightly modified procedure of the In stage I CRF we observed a slight (12%) rise in conjugated dienes in LDL, but the increase in MDA (15%) was negligible. This probably indicates that increase in oxidized LDL occurs prior to increase in MDA in CRF, which is in agreement with the above sequence of changes.
Although I~-carotene and vitamin E have not been 
